Capital Flow Monitor · Sponsors · CIK 1703764
Thrombolex, Inc.
4416 Route 27, Suite A, Kingston, NJ, 08528 · 844-792-6300
Other Health Care · Corporation· inc. DELAWARE true
Fit score
—
Offering
$51.1M
Sold
$32.8M
% sold
64.1%
Investors
22
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2026-03-12 | D ·current | 506(b) | $51.1M | $32.8M | 64.1% | 22 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Michael J. Cerminaro — Executive Officer / Director, Kingston, NJ
- Marvin Woodall — Executive Officer / Director, Kingston, NJ
- John Cerminaro — Executive Officer, Kingston, NJ
-
Paul A. Stewart — Director, Kingston, NJ
1 other raise
- PSCP Ice, LLC $3.9M of $3.9M · 100.0%
-
David Bonita — Director, Kingston, NJ
6 other raises
- PFARADIGM Health, Inc. $31.1M of $56.1M · 55.4%
- Alpfa Medical, Inc. $80.3M of $100.3M · 80.1%
- OrbiMed Partners II, L.P. $1.78B of —
- Treeline Biosciences, Inc. $200.1M of $250.0M · 80.0%
- Ikena Oncology, Inc. $0 of $75.0M · 0.0%
- Adela, Inc. $25.4M of $27.0M · 94.2%
- Sam Liang — Director, Kingston, NJ
- Keegan Harper — Director, Kingston, NJ
- Clay DeMarcus — Director, Kingston, NJ
Placement agents
- No sales compensation reported — direct raise.
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.